May 2012 FDA Recall Drug by Teva Pharmaceuticals Usa, Inc.
D-1409-2012 - Tablet Thickness

This Class II drug recall was voluntarily initiated by Teva Pharmaceuticals Usa, Inc. on May 16, 2012 for the product Drug. The FDA reported the reason for recall as tablet thickness. The product was distributed in Ohio and the recall is currently terminated.

Recall Number: D-1409-2012

Reason for Recall
Tablet Thickness: Potential for some tablets not conforming to weight specifications (under and over weight)
Initiated
05-16-2012
Reported
07-11-2012
Quantity
2,268 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Teva Pharmaceuticals USA, Inc.
Metoprolol Tartrate Tablets USP 50 mg, 1000 count bottle, Rx only, Manufactured in india By: Emcure Pharmaceuticals LTD. Hinjwadi, Pune, India, Manufactured for TEVA Phamaceuticals USA, Sellersville, PA 18960, NDC 0093-0733-10

Batch or Lot Expiration Information

Lot# TE1Y261, Exp, 12/2013